Abstract

Burns and other related ailments frequently result in fatalities and disabilities. Children and adults suffer burn cases at a higher rate than other age groups. Contact with hot surfaces and scald burns are the most typical hospital presentations in toddlers under the age of two. Some of the factors include the custom of cooking on the ground or sleeping next to a burning candle. Better outcomes are seen when this sort of burns are treated quickly. In this instance, we discuss the use of a hybrid reconstruction ladder in the treatment of pediatric scald burns.

• 1.   Tenenhaus M, Rennekampff HO. Surgical advances in burn and reconstructive plastic surgery: new and emerging technologies. Clin. Plast. Surg. 39(4), 435–443 (2012).
• 2.   Salazar-Álvarez AE, Riera-del-Moral LF, GarcíaArranz M, Alvarez-García J, ConcepciónRodriguez NA, Riera-de-Cubas L: Use of plateletrich plasma in the healing of chronic ulcers of the lower extremity. ActasDermosifiliogr 2014; 105:597-604.
• 3.   Picard F, Hersant B, Bosc R, Meningaud JP: Should we use platelet-rich plasma as an adjunct therapy to treat “acute wounds”, “burns”, and “laser therapies”: a review and a proposal of a quality criteria checklist for further studies. Wound Repair Regen 2015; 23:163-170.
• 4.   Cobos R, Aizpuru F, Parraza N, Anitua E, Orive G: Effectiveness and efficiency of platelet rich plasma in the treatment of diabetic ulcers. Curr Pharm Biotechnol 2015; 16:630-634.
• 5.   Tumino G, Masuelli L, Bei R, et al. Topical treatment of chronic venous ulcers with sucralfate: a placebo con-trolled randomized study. Int J Mol Med. 2008; 22:17.
• 6.   Gupta PJ, Heda PS, Shrirao SA, et al. Topical sucralfate treatment of anal fistulotomy wounds: a randomized placebo-controlled trial. Dis Colon Rectum. 2011; 54:699–704.
• 7.   Burch R, McMillan B. Sucralfate induces proliferation of dermal fibroblasts and keratinocytes in culture and granulation tissue formation in full-thickness skin wounds. Agents Actions. 1991; 34:229–231.
• 8.   Folkman J, Szabo S, Shing Y. Sucralfate affinity for fibro-blast growth factor. J Cell Biol. 1990;111: A223.
• 9.   Farivar S, Malekshahabi T, Shiari R. Biological Effects of LowLevel Laser Therapy. J Lasers Med Sci 2014; 5 (2):58-62.
• 10.   Andrade F, Rosana C, Manoel F. Effects of lowlevel laser therapy on wound healing. Rev. Col. Bras. Cir. 2014 Apr; 41(2):129-133.
• 11.   Avci P, Gupta A, Sadasivam M, Vecchio D, Pam Z, Pam N, et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. SeminCutan Med Surg. Panayi AC, Leavitt T, Orgill DP. Evidence based review of negative pressure wound therapy. World J Dermatol. 2017;6:1–16.
• 12.   Wynn M, Freeman S. The efficacy of negative pressure wound therapy for diabetic foot ulcers: a systematised review. J Tissue Viability. 2019;28 :152–160.2013; 32(1):41–510.
• 13.   Shukla VK, Tiwary SK, Barnwal S, Gulati AK, Pandey SS. Effect of autologous epidermal cell suspension transplantation in chronic nonhealing wounds: a pilot study. Can J Surg. 2010;53(1):6–10.
• 14.   Gauthier Y, Benzekri L. Non-cultured epidermal suspension in vitiligo: From laboratory to clinic. Indian J Dermatol VenereolLeprol 2012;78: 59-63.

Data Sharing Statement

Funding